SHW
46
3
PNW
63
4
DOV
76
-2
CCL
33
-6
EOG
37
-4
CHK
24
-10
HP
30
-3
ILMN
42
4
CHRW
44
2
INTU
65
-2
CVS
33
-15
DOW
46
2
EXPE
56
-3
ETN
78
-2
DVA
81
3
MOS
25
-5
SWN
60
-6
MCHP
55
-4
CHD
61
-3
SYY
48
-2
SHW
46
3
PNW
63
4
DOV
76
-2
CCL
33
-6
EOG
37
-4
CHK
24
-10
HP
30
-3
ILMN
42
4
CHRW
44
2
INTU
65
-2
CVS
33
-15
DOW
46
2
EXPE
56
-3
ETN
78
-2
DVA
81
3
MOS
25
-5
SWN
60
-6
MCHP
55
-4
CHD
61
-3
SYY
48
-2
Financhill
Back

Exelixis Quote, Financials, Valuation and Earnings

Will Crypto Make People Rich Again Starting April 2024?

Details on how to profit here.
Buy
54

EXEL
Exelixis

Last Price:
22.07
Seasonality Move:
6.45%

7 Day Trial

ALL ACCESS PASS

$ 7

20 Most Hated Stocks on Wall Street

Click here to see the full list and protect yourself before it's too late.

Exelixis Price Quote

$22.07
+0.15 (+0.68%)
(Updated: May 2, 2024 at 1:20 PM ET)

Exelixis Key Stats

Buy
54
Exelixis (EXEL) is a Buy
Day range:
$20.69 - $22.24
52-week range:
$18.52 - $24.34
Dividend yield:
0%
P/E ratio:
33.72
P/S ratio:
3.75
P/B ratio:
3%
Volume:
6.9M
Avg. volume:
2.2M
1-year change:
16.41%
Market cap:
$6.4B
Revenue:
$1.8B
EPS:
$0.64

How Much Does Exelixis Make?

  • How Much Are Exelixis's Sales Annually?
    EXEL Revenues are $1.8B
  • How Much Profit Does Exelixis's Make A Year?
    EXEL net income is $207.8M

Is Exelixis Growing As A Company?

  • What Is Exelixis's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.04%
  • What Is Exelixis's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Exelixis Stock Price Performance

  • Did Exelixis Stock Go Up Last Month?
    Exelixis share price went down by -7.43% last month
  • Did EXEL's Share Price Rise Over The Last Year?
    EXEL share price rose by 16.41% over the past 1 year

What Is Exelixis 52-Week High & Low?

  • What Is Exelixis’s 52-Week High Share Price?
    Exelixis has traded as high as $24.34 over the past 52 weeks
  • What Is Exelixis’s 52-Week Low Share Price?
    Exelixis has traded as low as $18.52 over the past 52 weeks

Exelixis Price To Free Cash Flow

  • Is Exelixis Stock Overvalued?
    Exelixis is trading at a price to free cash flow ratio of 37.45
  • Is Exelixis Stock Undervalued?
    Exelixis EV to Free Cash Flow ratio is 29.29
  • What Is Exelixis’s Price Earnings Growth Ratio?
    EXEL PEG ratio is 1.00
  • Is Exelixis Trading At A Premium To Earnings?
    Exelixis EV to EBIT ratio is 26.53

Is It Risky To Buy Exelixis?

  • How Much Debt Does Exelixis Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Exelixis Have?
    Cash and short term investments quarterly total is $963.3M
  • What Is Exelixis’s Book Value Per Share?
    Book value per share is 7.21

Is Exelixis Cash Flow Positive?

  • What Is EXEL Cash Flow From Operations?
    Cash flow from operations (TTM) is $317.7M
  • What Is Exelixis’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$734.7M
  • What Is Exelixis’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $134.4M

Exelixis Return On Invested Capital

  • Is Management Doing A Good Job?
    EXEL return on invested capital is 8.67%
  • What Is Exelixis Return On Assets?
    ROA measures how assets are converting to revenues and is 6.83%
  • What Is EXEL Return On Equity?
    ROE is a measure of profitability and is 8.67%

Exelixis Earnings Date & Stock Price

  • What Is Exelixis's Stock Price Today?
    A single share of EXEL can be purchased today for 21.92
  • What Is Exelixis’s Stock Symbol?
    Exelixis trades on the nasdaq under the ticker symbol: EXEL
  • When Is Exelixis’s Next Earnings Date?
    The next quarterly earnings date for Exelixis is scheduled on August 1, 2024
  • When Is EXEL's next ex-dividend date?
    Exelixis's next ex-dividend date is May 2, 2024
  • How To Buy Exelixis Stock?
    You can buy Exelixis shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Exelixis Competitors

  • Who Are Exelixis's Competitors?
    Below is a list of companies who compete with Exelixis or are related in some way:
    • Johnson & Johnson (JNJ)
    • Legend Biotech Corp (LEGN)
    • Merck & Co Inc (MRK)
    • Pfizer Inc (PFE)
    • Regeneron Pharmaceuticals Inc (REGN)

Exelixis Dividend Yield

Data Unavailable

Exelixis Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -40.65%
Revenue: 4.02% -7.65%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 26.54
Upside from Last Price: 21.09%

Major Shareholders

  • How many EXEL shares are owned by institutional investors?
    369.6M EXEL shares are owned by institutional investors
  • How many EXEL shares are owned by insiders?
    8.9M EXEL shares are owned by insiders